Article
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated…
Pharmacogenomics and Personalized Medicine · 2022 · Di Stefano V, Fava A, Gentile L, Guaraldi P, Leonardi L, Poli L, Tagliapietra M, Vastola M, Fanara S, Ferrero B, Giorgi M, Perfetto F, Russo M, Russo D
Key facts
| Title | Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran |
|---|---|
| First author | Di Stefano V, Fava A, Gentile L, Guaraldi P, Leonardi L, Poli L, Tagliapietra M, Vastola M, Fanara S, Ferrero B, Giorgi M, Perfetto F, Russo M, Russo D |
| Journal | Pharmacogenomics and Personalized Medicine |
| Published | May 12, 2022 |
| DOI | 10.2147/PGPM.S359851 |
| Devices mentioned | K791153 |
| Product codes mentioned | JAK |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1